(in million €) H2 2017 H2 2018 2017 2018
Recurring EBITDA (10) (16) (24) (35)
Recurring EBIT (16) (21) (36) (46)
   of which associates 10 2 18 5
Total EBIT (19) (22) (51) (39)
R&D expenditure 0 4 5 7
Capital expenditure 7 10 12 14
Capital employed, end of period 174 222 174 222
Capital employed, average 161 204 152 191
Workforce, end of period (fully consolidated) 1 009 1 070 1 009 1 070
Workforce, end of period (associates) 2 443 2 398 2 443 2 398